VERTEX PHARMACEUTICALS INCORPOR VRTX (NASDAQ) $ 22.15 Change: -0.17 -0.77% | Volume: 326,669
Sponsored by Click here!

VERTEX PHARM - Fundamental Profile

Company Information

Ticker Symbol: VRTX
Exchange: NASD
Contact Info: 130 Waverly Street Cambridge MA 02139-4242 617 444-6100
CEO/President: Joshua S. Boger Ph.D.
Industry: Medical - Biomedical / Standard Industry Code: 2834
Description: Vertex Pharmaceuticals Inc. discovers, develops and markets small molecule drugs that address major unmet medical needs. The company has eight drug candidates in clinical development to treat viral diseases, inflammation, cancer, autoimmune diseases and neurological disorders. Vertex has created its pipeline using a proprietary information-based approach to drug design that integrates multiple technologies in biology, chemistry and biophysics aimed at increasing the speed and success rate of drug discovery. (PRESS RELEASE)

Share Information

Shares Outstanding: 148,620 (000) Market Value: 3,511,880 ($000)
Percentage of Inst.Shareholders: 98.57% Number of Inst.Shareholders: 4.10%
Last Quarter Sales: 31.61 ($Mil.) Last Quarter Net Income: -130.04 ($Mil.)
Last Quarter EPS: -0.93 P/E Ratio: 0
Most Recent Earnings: -0.93 on 10/27/08 Earnings Per Share: -2.97
Most Recent Split: 2-1 on 08/24/00 Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN INC. +12.10 56.34
GILEAD SCIENCES -8.20 45.55
CELGENE CORPORA -16.00 52.78
GENENTECH INC -1.40 73.65
GENZYME CORPORA -21.90 61.21